share_log

TD Cowen Maintains Outperform on Calumet Specialty Prods, Raises Price Target to $23

TD Cowen Maintains Outperform on Calumet Specialty Prods, Raises Price Target to $23

TD Cowen维持Calumet专业产品的跑赢大盘,将目标股价上调至23美元
Benzinga ·  2023/05/08 07:33

TD Cowen analyst Jason Gabelman maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Outperform and raises the price target from $21 to $23.

道明考恩分析师杰森·加伯尔曼维持Calumet Specialty Prods(纳斯达克股票代码:CLMT)的跑赢大盘,并将目标股价从21美元上调至23美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发